Somatostatin biosimilar (Lunan Pharmaceutical)

生长抑素生物类似药(鲁南制药)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatostatin biosimilar (Lunan Pharmaceutical)
Drug Alias Name生长抑素生物仿制药(鲁南制药)Somatostatin follow-on biologic
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsDiabetes MellitusGastrointestinal Diseases
Global Approved IndicationsDiabetes MellitusGastrointestinal Diseases
Approved Indications in ChinaDiabetes MellitusGastrointestinal Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date2005/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLunan Pharmaceutical Group Co
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes MellitusGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeH01CB01
Related LinksN/A